In 2006, Edward Gilhuly and Scott Stuart founded Sageview Capital, an investment firm that has about $800 million in assets under management. The strategy employed by Sageview involves focusing on long-term investments with a strong fundamental foundation.
Sageview, in its latest 13F, has disclosed its holdings as held at the end of the fourth quarter of 2013. The value of the fund’s equity portfolio totaled $352.09 million, up from $334.48 million in the third quarter.
In this article, we will talk about the positions revealed by Sageview Capital in its latest 13F. The first on the list is EverBank Financial Corp (NYSE:EVER), in which the fund disclosed owning 12.91 million shares, with a reported value of $236.81 million. The stake remained unchanged over the quarter. EverBank Financial Corp (NYSE:EVER), which provides a diverse range of financial products and services directly to clients nationwide through multiple business channels, reported fourth-quarter 2013 adjusted net income of $32 million, compared to $34 million for the third quarter 2013 and $44 million for the fourth quarter of 2012.
COMSCORE, Inc. (NASDAQ:SCOR) is the second most valuable holding. In the company, the fund reduced its position to 1.90 million shares in the fourth quarter from 2.04 million held at the end of the third quarter. The value of holding is $54.47 million. COMSCORE, Inc. (NASDAQ:SCOR) is a provider of digital measurement and analytics.
On the third spot is Resolute Energy Corp (NYSE:REN), in which the fund revealed ownership of 5.08 million shares, worth $45.84 million. There was no change in number of shares from the previous quarter. Resolute Energy Corp (NYSE:REN) is engaged in the exploitation, development, exploration for and acquisition of oil and gas properties.
The fourth-largest holding is Envivio Inc (NASDAQ:ENVI), in which Sageview disclosed holding 2.61 million shares, with a reported value of $8.87 million. The stake remained unchanged over the quarter. Envivio Inc (NASDAQ:ENVI) provides software-based video processing and delivery solutions.
The fifth position is held by Pernix Therapeutics Holdings Inc (NASDAQ:PTX), a specialty pharmaceutical company primarily focused on the sales, marketing, manufacturing and development of branded pharmaceutical products. The fund owns 2.22 million shares of the company, unchanged from the third quarter. The value of holding is $5.60 million.
The sixth-position is represented by Cinedigm Corp (NASDAQ:CIDM), in which Sageview Capital disclosed holding 248,846 shares, with a reported value of $503,000. The stake remained unchanged over the quarter.